The Food and Drug Administration's medical device approval processwas taken to task this month in a report presented to a congressionalsubcommittee. The report portrayed the FDA's Center for Devices and RadiologicalHealth (CDRH) as plagued by
The Food and Drug Administration's medical device approval processwas taken to task this month in a report presented to a congressionalsubcommittee.
The report portrayed the FDA's Center for Devices and RadiologicalHealth (CDRH) as plagued by inefficient use of resources and apervasive bias in favor of device manufacturers.
The report quotes FDA device reviewers as stating that:
The report was presented to the House of Representatives subcommitteeon oversight and investigations by subcommittee investigator ThomasDorney, who sent confidential questionnaires to FDA device reviewers.
Although many questionnaires are still outstanding, about halfof those that have been returned claim that politics sometimescarries as much weight as science in the device approval process.
"A reviewer who completed the questionnaire (pointed out)the title of the Office of Device Evaluation should be changedto Office of Device Approval," Dorney said.
The chaotic approval process has the effect of penalizing firmswith well-made devices while benefiting companies that aren'tas well prepared or as competent, Dorney said.
FDA representatives at the subcommittee hearing responded byacknowledging that problems exist within the device approval process,but claimed the agency is moving quickly to remedy them. The FDAhas appointed a new ODE director with a strong scientific background,has launched a series of internal audits of the approval processand has appointed an integrity officer.
Reform of the agency's approval process is needed, said subcommitteechairman John Dingell (D-MI). However, any such reform must bedone without "bringing the approval process to a grindinghalt," he said.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.